Prognostic false-positivity and cost-effectiveness in sentinel node biopsy in melanoma

Ann Surg Oncol. 2009 Oct;16(10):2961; author reply 2962-3. doi: 10.1245/s10434-009-0587-1. Epub 2009 Jul 1.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Cost-Benefit Analysis
  • False Positive Reactions
  • Humans
  • Melanoma / economics*
  • Melanoma / surgery
  • Prognosis
  • Sentinel Lymph Node Biopsy / economics*